Plain-English translation of NCT07375420 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Esophageal cancer is difficult to treat, and new approaches are needed to improve survival. This trial is testing whether a supervised exercise program — done at different intensity levels — can help wake up your immune system while you receive chemotherapy before surgery. The hope is that exercise may make your existing cancer treatment work better by increasing immune cells that can fight the cancer.
Many esophageal tumors don't have enough active immune cells to respond well to immunotherapy. Exercise has shown promise in other cancers by increasing immune cell activity and changing the bacteria in your gut, which can influence how your immune system works. This study will explore whether exercise during chemotherapy can harness these benefits for people with esophageal cancer.
You likely qualify if…
You likely don't qualify if…
You will join a supervised exercise program while receiving your planned chemotherapy. All participants will exercise under the guidance of specialist staff, but you'll be randomly assigned to either a lower-intensity program (similar to standard NHS prehabilitation) or a higher-intensity program (within safe limits). The researchers will monitor your immune cells, gut bacteria, and how your body responds to see whether exercise intensity makes a difference in your treatment outcomes.
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
United Kingdom